Legal Disclaimer

Read together with the Terms of Use and Privacy Policy.

Please read this disclaimer together with our Terms of Use and our Privacy Policy. By using this website and our consultation service, you acknowledge and accept the following.

NGS Advisory reviews an existing next-generation sequencing (NGS) / molecular report in light of current guidelines and published literature, and provides a structured, calibrated second opinion. The content of this website and our reports is for informational and educational purposes and serves as a decision-support resource for the treating physician.

It does not make a diagnosis, prescribe medication, or direct treatment. It is only one of many expert opinions considered by the treating physician.

Using this website, reading its content, or submitting a report for review does not, by itself, establish a physician-patient relationship or constitute an examination. Our assessment is based on the documents submitted to us; we do not examine the patient and, unless it is provided to us, we do not have access to the complete clinical record.

Always consult your physician

Never disregard or delay seeking professional medical advice because of something you have read on this website or in our report. Always discuss any change to your care with your treating physician.

All clinical decisions are made by the physician together with the patient, based on the complete clinical picture.

All clinical decisions — including starting, changing, or discontinuing any treatment — are made solely by the treating physician together with the patient, taking into account the complete clinical picture. NGS Advisory does not assume responsibility for treatment decisions; it provides layered evidence and options for the physician's evaluation.

No clinical outcome, treatment response, or eligibility for research can be guaranteed.

Medicine and molecular oncology are uncertain and constantly evolving. We apply current evidence and careful judgment, but we cannot and do not guarantee any particular clinical outcome, response to treatment, eligibility for a clinical trial, or that every relevant option has been identified. Genomic interpretation may change as guidelines, evidence, and testing are updated.

References to drugs, off-label options, or trials are not recommendations or endorsements.

Where our content refers to drug classes, off-label options, or clinical trials, this is for informational purposes only and does not constitute a recommendation, endorsement, or prescription. Approval status, availability, and reimbursement vary by country and change over time. Off-label use and participation in research carry their own risks and must be evaluated and supervised by the treating physician and, where relevant, the research team.

We do not use brand names as an endorsement; drugs are generally referred to at the class level.

References to external sources are for transparency; they do not constitute endorsement.

Our content refers to external sources (such as guideline bodies and scientific literature) for the sake of transparency. We are not responsible for the content, accuracy, or availability of third-party websites, and a reference or link does not constitute an endorsement.

Harm arising from reliance beyond the appropriate scope is excluded; mandatory liability is reserved.

To the maximum extent permitted by applicable law, NGS Advisory and its operator are not liable for any harm arising from reliance on this website or on our consultation beyond the appropriate scope described above. This disclaimer does not exclude or limit any liability that cannot be excluded or limited under applicable law. Our consultation should be read together with the full report and the assessment of the treating physician.